Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Advanced Solid Tumor × conteltinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

tislelizumab 2 Oxaliplatin 2 trastuzumab deruxtecan 1 toripalimab 1 enfortumab vedotin 1 conteltinib 1 Pemetrexed 1 Paclitaxel 1 Leucovorin 1 Injections 1 Gemcitabine 1 Fluorouracil 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 CD3 Complex 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06970132 2025-05-14

Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation

Shouyao Holdings (Beijing) Co. LTD

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡